ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company developing, manufacturing, and commercializing innovative and high-quality therapeutics as we transform into a leading Rare Disease company.
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
2026-01-12
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
2026-01-06
$81.33
-1.66 ( -2% )
Pricing delayed by 20 minutes
Last updated
2026-01-26 16:00:00